Literature DB >> 20689555

p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.

M Aoubala1, F Murray-Zmijewski, M P Khoury, K Fernandes, S Perrier, H Bernard, A-C Prats, D P Lane, J-C Bourdon.   

Abstract

We have previously reported that the human p53 gene encodes at least nine different p53 isoforms, including Δ133p53α, which can modulate p53 transcriptional activity and apoptosis. In this study, we aimed to investigate the regulation of Δ133p53α isoform expression and its physiological role in modulating cell cycle arrest and apoptosis. We report here that in response to a low dose of doxorubicin (which induces cell cycle arrest without promoting apoptosis), p53 directly transactivates the human p53 internal promoter, inducing Δ133p53α protein expression. The induced Δ133p53α then inhibits p53-dependent apoptosis and G1 arrest without inhibiting p53-dependent G2 arrest. Therefore, endogenous Δ133p53α does not exclusively function in a dominant-negative manner toward p53, but differentially regulates cell cycle arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20689555      PMCID: PMC3039296          DOI: 10.1038/cdd.2010.91

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  31 in total

1.  Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.

Authors:  Mark K Saville; Alison Sparks; Dimitris P Xirodimas; Julie Wardrop; Lauren F Stevenson; Jean-Christophe Bourdon; Yvonne L Woods; David P Lane
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

2.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

3.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

Authors:  T Juven; Y Barak; A Zauberman; D L George; M Oren
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

4.  Transcriptional repression by the C-terminal domain of p53.

Authors:  E Shaulian; I Haviv; Y Shaul; M Oren
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

5.  Bromodeoxyuridine/DNA analysis of replication in CHO cells after exposure to UV light.

Authors:  C A Hoy; C Carswell; R T Schimke
Journal:  Mutat Res       Date:  1993-12       Impact factor: 2.433

6.  p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.

Authors:  Kaori Fujita; Abdul M Mondal; Izumi Horikawa; Giang H Nguyen; Kensuke Kumamoto; Jane J Sohn; Elise D Bowman; Ewy A Mathe; Aaron J Schetter; Sharon R Pine; Helen Ji; Borivoj Vojtesek; Jean-Christophe Bourdon; David P Lane; Curtis C Harris
Journal:  Nat Cell Biol       Date:  2009-08-23       Impact factor: 28.824

Review 7.  p63 and p73: roles in development and tumor formation.

Authors:  Ute M Moll; Neda Slade
Journal:  Mol Cancer Res       Date:  2004-07       Impact factor: 5.852

8.  Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.

Authors:  Y Barak; E Gottlieb; T Juven-Gershon; M Oren
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

9.  Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

Authors:  C A Midgley; C J Fisher; J Bártek; B Vojtĕsek; D Lane; D M Barnes
Journal:  J Cell Sci       Date:  1992-01       Impact factor: 5.285

10.  Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane.

Authors:  J-C Bourdon; J Renzing; P L Robertson; K N Fernandes; D P Lane
Journal:  J Cell Biol       Date:  2002-07-22       Impact factor: 10.539

View more
  57 in total

1.  Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.

Authors:  Olivier Terrier; Virginie Marcel; Gaëlle Cartet; David P Lane; Bruno Lina; Manuel Rosa-Calatrava; Jean-Christophe Bourdon
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  p53 coordinates with Δ133p53 isoform to promote cell survival under low-level oxidative stress.

Authors:  Lu Gong; Xiao Pan; Zhi-Min Yuan; Jinrong Peng; Jun Chen
Journal:  J Mol Cell Biol       Date:  2015-12-23       Impact factor: 6.216

3.  Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.

Authors:  Marco M Candeias; Masatoshi Hagiwara; Michiyuki Matsuda
Journal:  EMBO Rep       Date:  2016-10-04       Impact factor: 8.807

4.  Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation.

Authors:  M-L Dichtel-Danjoy; D Ma; P Dourlen; G Chatelain; F Napoletano; M Robin; M Corbet; C Levet; H Hafsi; P Hainaut; H D Ryoo; J-C Bourdon; B Mollereau
Journal:  Cell Death Differ       Date:  2012-08-17       Impact factor: 15.828

5.  p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage.

Authors:  Lu Gong; Hongjian Gong; Xiao Pan; Changqing Chang; Zhao Ou; Shengfan Ye; Le Yin; Lina Yang; Ting Tao; Zhenhai Zhang; Cong Liu; David P Lane; Jinrong Peng; Jun Chen
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

6.  The significance of p53 isoform expression in serous ovarian cancer.

Authors:  Setsuko K Chambers; Jesse D Martinez
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

7.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

Review 8.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 9.  A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation.

Authors:  Marina Kazantseva; Sunali Mehta; Ramona A Eiholzer; Noelyn Hung; Anna Wiles; Tania L Slatter; Antony W Braithwaite
Journal:  Mamm Genome       Date:  2018-07-10       Impact factor: 2.957

10.  The p53 isoforms are differentially modified by Mdm2.

Authors:  Suzanne Camus; Sergio Ménendez; Kenneth Fernandes; Nelly Kua; Geng Liu; Dimitris P Xirodimas; David P Lane; Jean-Christophe Bourdon
Journal:  Cell Cycle       Date:  2012-04-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.